SPONSOR
Ipsen
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: PFIC - Progressive Familial Intrahepatic CholestasisNeuroendocrine TumorsPrimary Biliary Cholangitis (PBC)Advanced Solid Tumor
Ipsen is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including PFIC - Progressive Familial Intrahepatic Cholestasis, Neuroendocrine Tumors, Primary Biliary Cholangitis (PBC), Advanced Solid Tumor.
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ipsen
How many clinical trials has Ipsen sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Ipsen, of which 4 are actively recruiting participants. These trials cover conditions including PFIC - Progressive Familial Intrahepatic Cholestasis, Neuroendocrine Tumors, Primary Biliary Cholangitis (PBC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ipsen research focus on?
Ipsen clinical trials span PFIC - Progressive Familial Intrahepatic Cholestasis, Neuroendocrine Tumors, Primary Biliary Cholangitis (PBC), Advanced Solid Tumor. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ipsen clinical trial?
To participate in a Ipsen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ipsen trials with current recruitment status updated daily.
Clinical Trials by Ipsen
NCT07191704
Recruiting
A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain
PFIC - Progressive Familial Intrahepatic Cholestasis
NCT07314164
Recruiting
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Neuroendocrine Tumors
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
NCT06833008 Phase 1, Phase 2
Recruiting
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
Advanced Solid Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology